Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
31,200,014
-
Shares change
-
+7,866,508
-
Total reported value, excl. options
-
$149,783,918
-
Value change
-
+$47,689,218
-
Put/Call ratio
-
1.8%
-
Number of buys
-
94
-
Number of sells
-
-31
-
Price
-
$4.8
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q2 2024
145 filings reported holding HUMA - Humacyte, Inc. - COM as of Q2 2024.
Humacyte, Inc. - COM (HUMA) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,200,014 shares
.
Largest 10 shareholders include BlackRock Inc. (7,140,014 shares), VANGUARD GROUP INC (4,729,594 shares), STATE STREET CORP (2,868,626 shares), GEODE CAPITAL MANAGEMENT, LLC (1,861,098 shares), MILLENNIUM MANAGEMENT LLC (1,599,307 shares), Nuveen Asset Management, LLC (1,243,678 shares), TWO SIGMA INVESTMENTS, LP (1,142,042 shares), GOLDMAN SACHS GROUP INC (761,575 shares), VOLORIDGE INVESTMENT MANAGEMENT, LLC (687,296 shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (654,372 shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.